Overview

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
We will evaluate the bioavailability of naproxen 375 mg in two formulations
Phase:
Phase 1
Details
Lead Sponsor:
POZEN
Treatments:
Naproxen